{"nct_id":"NCT05742607","title":"IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)","status":"RECRUITING","status_verified_date":"2025-05","start_date":"2023-06-23","start_date_type":"ACTUAL","primary_completion_date":"2025-06","primary_completion_date_type":"ESTIMATED","completion_date":"2026-09","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["IPHA"]}